Guillain-Barré syndrome risk factors

Jump to navigation Jump to search

Guillain-Barré syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Guillain-Barré syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural history, Complications, and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Guillain-Barré syndrome risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Guillain-Barré syndrome risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Guillain-Barré syndrome risk factors

CDC on Guillain-Barré syndrome risk factors

Guillain-Barré syndrome risk factors in the news

Blogs on Guillain-Barré syndrome risk factors

Directions to Hospitals Treating Guillain-Barré syndrome

Risk calculators and risk factors for Guillain-Barré syndrome risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editors-In-Chief: Priyamvada Singh, MBBS [2]

Overview

Guillain-Barré syndrome (GBS) is an acute, autoimmune, polyradiculoneuropathy affecting the peripheral nervous system, usually triggered by an acute infectious process. Anyone can develop GBS; however, it is more common among older adults. The incidence of GBS increases with age, and people older than 50 years are at greatest risk for developing GBS. Since 1976, many studies have been done to see if other flu vaccines may cause GBS. In most studies no link was found between the flu vaccine and GBS. For the most part, the chance of getting very ill from flu is far higher than the chance of getting GBS after getting the flu vaccine [1], [2].

Risk factors

  • Anyone can develop Guillain-Barré syndrome; however, it is more common among older adults. The incidence of GBS increases with age, and people older than 50 years are at greatest risk for developing GBS.
  • In 1976 there was a small increased risk of GBS following vaccination with an influenza vaccine made to protect against a swine flu virus.
  • Since 1976, many studies have been done to see if other flu vaccines may cause GBS. In most studies no link was found between the flu vaccine and GBS.
  • However, two studies did suggest that about 1 more person out of 1 million people vaccinated with seasonal flu vaccine may develop GBS. This continues to be studied.
  • The Institute of Medicine (IOM) conducted a thorough scientific review of this issue in 2003 and concluded that people who received the 1976 swine influenza vaccine had an increased risk for developing GBS.
  • Scientists have multiple theories on why this increased risk may have occurred, but the exact reason for this association remains unknown.
  • It is important to keep in mind that severe illness and death are associated with influenza, and vaccination is the best way to prevent influenza infection and its complications. For the most part, the chance of getting very ill from flu is far higher than the chance of getting GBS after getting the flu vaccine.
  • CDC and FDA are still assessing the association of Menactra Meningococcal conjugate vaccine with GBS. However, at this time there is no firm evidence to say that Menactra causes GBS.

External link

link name

References

  1. Kuitwaard K, Bos-Eyssen ME, Blomkwist-Markens PH, van Doorn PA (2009). "Recurrences, vaccinations and long-term symptoms in GBS and CIDP". Journal of the Peripheral Nervous System : JPNS. 14 (4): 310–5. doi:10.1111/j.1529-8027.2009.00243.x. PMID 20021573. Retrieved 2012-02-23. Unknown parameter |month= ignored (help)
  2. Dieleman J, Romio S, Johansen K, Weibel D, Bonhoeffer J, Sturkenboom M (2011). "Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe". BMJ (Clinical Research Ed.). 343: d3908. PMC 3134565. PMID 21750072. Retrieved 2012-02-23.

Template:WH Template:WS